BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM

BioPlus Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
1.17M n/a
Gross Profit
-1.17M n/a
Operating Income
-1.17M -162.43
Interest Income
3.17M 9.49
Pretax Income
2M -152.94
Net Income
5.16M -152.94
Selling & General & Admin
1.17K 162.43
Research & Development
n/a n/a
Other Expenses
n/a n/a
Operating Expenses
1.17K 162.43
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
1.17M 162.43
Income Tax Expense
-3.17M n/a
Shares Outstanding (Basic)
597.79M 6.88K
Shares Outstanding (Diluted)
26.43M 6.88K
EPS (Basic)
0.01 -0.02
EPS (Diluted)
0.20 -0.02
EBITDA
-1.17M 9.49
EBIT
n/a n/a
Depreciation & Amortization
228.49K 236.56K